{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:07:53Z","timestamp":1793329673276,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["2023-00265820"],"award-info":[{"award-number":["2023-00265820"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2018IP0622"],"award-info":[{"award-number":["2018IP0622"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81089-4","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T23:04:54Z","timestamp":1736031894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Susceptibility map-weighted MRI can distinguish tremor-dominant Parkinson\u2019s disease from essential tremor"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5097-2340","authenticated-orcid":false,"given":"Sungyang","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-0530","authenticated-orcid":false,"given":"Chong Hyun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2252-7762","authenticated-orcid":false,"given":"Sangjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-3256","authenticated-orcid":false,"given":"Jihyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1042-5822","authenticated-orcid":false,"given":"MyungKi","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6103-4680","authenticated-orcid":false,"given":"Hwon","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-2916","authenticated-orcid":false,"given":"Woo Hyun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7070-7333","authenticated-orcid":false,"given":"Sang Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-4098","authenticated-orcid":false,"given":"Eung Yeop","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4118-8233","authenticated-orcid":false,"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"81089_CR1","unstructured":"Launch of WHO\u2019s Parkinson disease technical brief. https:\/\/www.who.int\/news\/item\/14-06-2022-launch-of-who-s-parkinson-disease-technical-brief."},{"key":"81089_CR2","unstructured":"Principles and practice of movement disorders."},{"key":"81089_CR3","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1212\/wnl.0000000000005215","volume":"90","author":"MF Dirkx","year":"2018","unstructured":"Dirkx, M. F., Zach, H., Bloem, B. R., Hallett, M. & Helmich, R. C. The nature of postural tremor in Parkinson disease. Neurology 90, e1095\u2013e1103. https:\/\/doi.org\/10.1212\/wnl.0000000000005215 (2018).","journal-title":"Neurology"},{"key":"81089_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/archneur.63.8.1100","volume":"63","author":"S Jain","year":"2006","unstructured":"Jain, S., Lo, S. E. & Louis, E. D. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch. Neurol. 63, 1100\u20131104. https:\/\/doi.org\/10.1001\/archneur.63.8.1100 (2006).","journal-title":"Arch. Neurol."},{"key":"81089_CR5","doi-asserted-by":"publisher","first-page":"e209453","DOI":"10.1212\/wnl.0000000000209453","volume":"102","author":"A Hastings","year":"2024","unstructured":"Hastings, A. et al. Neuropathologic validation and diagnostic accuracy of presynaptic dopaminergic imaging in the diagnosis of Parkinsonism. Neurology 102, e209453. https:\/\/doi.org\/10.1212\/wnl.0000000000209453 (2024).","journal-title":"Neurology"},{"key":"81089_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13550-015-0087-1","volume":"5","author":"SR Suwijn","year":"2015","unstructured":"Suwijn, S. R. et al. The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson\u2019s disease or clinically uncertain parkinsonism: a systematic review. EJNMMI Res. 5, 12. https:\/\/doi.org\/10.1186\/s13550-015-0087-1 (2015).","journal-title":"EJNMMI Res."},{"key":"81089_CR7","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1007\/s00330-020-07627-6","volume":"31","author":"PH Kim","year":"2021","unstructured":"Kim, P. H. et al. Diagnostic performance of loss of nigral hyperintensity on susceptibility-weighted imaging in parkinsonism: an updated meta-analysis. Eur. Radiol. 31, 6342\u20136352. https:\/\/doi.org\/10.1007\/s00330-020-07627-6 (2021).","journal-title":"Eur. Radiol."},{"key":"81089_CR8","doi-asserted-by":"publisher","first-page":"20180842","DOI":"10.1259\/bjr.20180842","volume":"92","author":"EY Kim","year":"2019","unstructured":"Kim, E. Y., Sung, Y. H. & Lee, J. Nigrosome 1 imaging: technical considerations and clinical applications. Br. J. Radiol. 92, 20180842. https:\/\/doi.org\/10.1259\/bjr.20180842 (2019).","journal-title":"Br. J. Radiol."},{"key":"81089_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/mdc3.13091","volume":"8","author":"H Kathuria","year":"2021","unstructured":"Kathuria, H. et al. Utility of imaging of Nigrosome-1 on 3T MRI and its comparison with 18F-DOPA PET in the diagnosis of idiopathic Parkinson disease and atypical parkinsonism. Mov. Disord. Clin. Pract. 8, 224\u2013230. https:\/\/doi.org\/10.1002\/mdc3.13091 (2021).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"81089_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5334\/tohm.604","volume":"11","author":"G Bienes","year":"2021","unstructured":"Bienes, G. et al. Neuroimaging assessment of nigrosome 1 with a multiecho gre magnetic resonance sequence in the differentiation between Parkinsons disease from essential tremor and healthy individuals. Tremor Other Hyperkinet. Mov. (N. Y.) 11, 17. https:\/\/doi.org\/10.5334\/tohm.604 (2021).","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y.)"},{"key":"81089_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fneur.2019.00100","volume":"10","author":"L Jin","year":"2019","unstructured":"Jin, L. et al. Combined visualization of Nigrosome-1 and neuromelanin in the Substantia nigra using 3T MRI for the differential diagnosis of essential tremor and de novo Parkinson\u2019s disease. Front. Neurol. 10, 100. https:\/\/doi.org\/10.3389\/fneur.2019.00100 (2019).","journal-title":"Front. Neurol."},{"key":"81089_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/1971400919853787","volume":"32","author":"MS Perez Akly","year":"2019","unstructured":"Perez Akly, M. S. et al. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson\u2019s disease and essential tremor. Neuroradiol. J. 32, 395\u2013400. https:\/\/doi.org\/10.1177\/1971400919853787 (2019).","journal-title":"Neuroradiol. J."},{"key":"81089_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/jmri.25553","volume":"46","author":"Y Nam","year":"2017","unstructured":"Nam, Y., Gho, S. M., Kim, D. H., Kim, E. Y. & Lee, J. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI). J. Magn. Reson. Imaging. 46, 528\u2013536. https:\/\/doi.org\/10.1002\/jmri.25553 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"key":"81089_CR14","doi-asserted-by":"publisher","first-page":"109398","DOI":"10.1016\/j.ejrad.2020.109398","volume":"134","author":"YJ Bae","year":"2021","unstructured":"Bae, Y. J. et al. Comparison of susceptibility-weighted imaging and susceptibility map-weighted imaging for the diagnosis of parkinsonism with nigral hyperintensity. Eur. J. Radiol. 134, 109398. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109398 (2021).","journal-title":"Eur. J. Radiol."},{"key":"81089_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3988\/jcn.2018.14.1.90","volume":"14","author":"EY Kim","year":"2018","unstructured":"Kim, E. Y. et al. Diagnosis of early-stage idiopathic Parkinson\u2019s disease using high-resolution quantitative susceptibility mapping combined with histogram analysi in the Substantia Nigra at 3 T. J. Clin. Neurol. 14, 90\u201397. https:\/\/doi.org\/10.3988\/jcn.2018.14.1.90 (2018).","journal-title":"J. Clin. Neurol."},{"key":"81089_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mrm.24920","volume":"72","author":"SM Gho","year":"2014","unstructured":"Gho, S. M. et al. Susceptibility map-weighted imaging (SMWI) for neuroimaging. Magn. Reson. Med. 72, 337\u2013346. https:\/\/doi.org\/10.1002\/mrm.24920 (2014).","journal-title":"Magn. Reson. Med."},{"key":"81089_CR17","doi-asserted-by":"publisher","first-page":"908298","DOI":"10.3389\/fmolb.2022.908298","volume":"9","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Modified Iron deposition in nigrosomes by pharmacotherapy for the management of Parkinson\u2019s disease. Front. Mol. Biosci. 9, 908298. https:\/\/doi.org\/10.3389\/fmolb.2022.908298 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"81089_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1586\/ern.12.49","volume":"12","author":"MA Thenganatt","year":"2012","unstructured":"Thenganatt, M. A. & Louis, E. D. Distinguishing essential tremor from Parkinson\u2019s disease: bedside tests and laboratory evaluations. Expert Rev. Neurother. 12, 687\u2013696. https:\/\/doi.org\/10.1586\/ern.12.49 (2012).","journal-title":"Expert Rev. Neurother."},{"key":"81089_CR19","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt, P. M. et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351, h5527. https:\/\/doi.org\/10.1136\/bmj.h5527 (2015).","journal-title":"BMJ"},{"key":"81089_CR20","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424 (2015).","journal-title":"Mov. Disord."},{"key":"81089_CR21","unstructured":"Liang, T. W. Essential tremor: Clinical features and diagnosis. https:\/\/www.uptodate.com\/contents\/essential-tremor-clinical-features-and-diagnosis#H3191471449 (2022)."},{"key":"81089_CR22","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1007\/s00330-021-08454-z","volume":"32","author":"YH Sung","year":"2022","unstructured":"Sung, Y. H. et al. A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism. Eur. Radiol. 32, 3597\u20133608. https:\/\/doi.org\/10.1007\/s00330-021-08454-z (2022).","journal-title":"Eur. Radiol."},{"key":"81089_CR23","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3174\/ajnr.A4412","volume":"36","author":"Y Noh","year":"2015","unstructured":"Noh, Y., Sung, Y. H., Lee, J. & Kim, E. Y. Nigrosome 1 detection at 3T MRI for the diagnosis of early-stage idiopathic Parkinson Disease: Assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality. AJNR Am. J. Neuroradiol. 36, 2010\u20132016. https:\/\/doi.org\/10.3174\/ajnr.A4412 (2015).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"81089_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/jon.12944","volume":"32","author":"S Haller","year":"2022","unstructured":"Haller, S., Davidsson, A., Tisell, A., Ochoa-Figueroa, M. & Georgiopoulos, C. MRI of nigrosome-1: a potential triage tool for patients with suspected Parkinsonism. J. Neuroimaging 32, 273\u2013278. https:\/\/doi.org\/10.1111\/jon.12944 (2022).","journal-title":"J. Neuroimaging"},{"key":"81089_CR25","doi-asserted-by":"publisher","unstructured":"Schmidt, M. A. et al. Ultra high-field SWI of the substantia nigra at 7T: reliability and consistency of the swallow-tail sign. BMC Neurol. 17. https:\/\/doi.org\/10.1186\/s12883-017-0975-2 (2017).","DOI":"10.1186\/s12883-017-0975-2"},{"key":"81089_CR26","doi-asserted-by":"publisher","first-page":"15133","DOI":"10.1523\/jneurosci.3739-14.2014","volume":"34","author":"KM Costa","year":"2014","unstructured":"Costa, K. M. The effects of aging on substantia nigra dopamine neurons. J. Neurosci. 34, 15133\u201315134. https:\/\/doi.org\/10.1523\/jneurosci.3739-14.2014 (2014).","journal-title":"J. Neurosci."},{"key":"81089_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1001\/archneur.55.6.823","volume":"55","author":"ED Louis","year":"1998","unstructured":"Louis, E. D., Ford, B., Lee, H., Andrews, H. & Cameron, G. Diagnostic criteria for essential tremor: a population perspective. Arch. Neurol. 55, 823\u2013828. https:\/\/doi.org\/10.1001\/archneur.55.6.823 (1998).","journal-title":"Arch. Neurol."},{"key":"81089_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000109681","volume":"16","author":"ED Louis","year":"1997","unstructured":"Louis, E. D. et al. The Washington heights-inwood genetic study of essential tremor: Methodologic issues in essential-tremor research. Neuroepidemiology 16, 124\u2013133. https:\/\/doi.org\/10.1159\/000109681 (1997).","journal-title":"Neuroepidemiology"},{"key":"81089_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2013.582","volume":"70","author":"J Prodoehl","year":"2013","unstructured":"Prodoehl, J. et al. Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. JAMA Neurol. 70, 100\u2013106. https:\/\/doi.org\/10.1001\/jamaneurol.2013.582 (2013).","journal-title":"JAMA Neurol."},{"key":"81089_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/hbm.23863","volume":"39","author":"YH Sung","year":"2018","unstructured":"Sung, Y. H. et al. Differential involvement of nigral subregions in idiopathic parkinson\u2019s disease. Hum. Brain Mapp. 39, 542\u2013553. https:\/\/doi.org\/10.1002\/hbm.23863 (2018).","journal-title":"Hum. Brain Mapp."},{"key":"81089_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger, G. U. et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 23, 191\u2013204. https:\/\/doi.org\/10.1016\/s1474-4422(23)00404-0 (2024).","journal-title":"Lancet Neurol."},{"key":"81089_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer, T. S. et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov. Disord. 15, 503\u2013510 (2000).","journal-title":"Mov. Disord."},{"key":"81089_CR33","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2967\/jnumed.112.105379","volume":"54","author":"K Tatsch","year":"2013","unstructured":"Tatsch, K. & Poepperl, G. Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update. J. Nucl. Med. 54, 1331\u20131338. https:\/\/doi.org\/10.2967\/jnumed.112.105379 (2013).","journal-title":"J. Nucl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81089-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T12:04:36Z","timestamp":1736078676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81089-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["81089"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81089-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"7 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Asan Medical Center Institutional Review Board (2022-0138).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for informed consent was waived by the ethical committee of the Asan Medical Center due to the retrospective design and low risk to participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publish"}}],"article-number":"823"}}